S03-05 OA. A less differentiated memory phenotype of Gag-specific CD4+ T-cells during primary HIV infection associates with viral control at 12 months

por Maenetje, PW, Casazza, J, Riou, C, Ambrozak, D, Gray, G, de Bruyn, G, Koup, R, Gray, C
Publicado 2009

RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues

por Liyanage, NP, Pegu, P, Gordon, S, Cameron, M, Foulds, K, Doster, M, Vaccari, M, Koup, R, Roederer, M, Sékaly, R, Franchini, G
Publicado 2012

Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses

por Riou, C, Abrahams, M, Mlisana, K, Koup, R, Roederer, M, Karim, S Abdool, de Bruyn, G, Williamson, C, Gray, CM, Burgers, WA
Publicado 2012

P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys

por Letvin, N, Mascola, J, Rao, S, Buzby, A, Roederer, M, Hudgens, M, Gilbert, P, Seder, R, Douek, D, Koup, R, Graham, B, Nabel, G
Publicado 2009

P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001

por Huang, Y, Sato, A, Wood, B, Gill, D, Kochar, N, Tarragona, T, Sambor, A, Wan, H, Levine, G, Self, S, Koup, R, Cox, J, Bailer, R, Gilmour, J
Publicado 2009

P832: CLINICAL OUTCOMES AND IMMUNE RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA

por Rajput, R., Ma, X., Boswell, K. L., Gaudinski, M., Groarke, E. M., Lotter, J., Rios, O., Darden, I., Wu, C. O., Koup, R. A., Young, N. S., Patel, B.
Publicado 2022

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers

por Caskey, M, Trumpfheller, C, Pollak, S, Sinnenberg, L, Hurley, A, Pring, J, Shimeliovich, I, Yipp, B, Anandasabapathy, N, Mehandru, S, Sarma, P, Koup, R, Bailer, R, Tomaras, G, Sato, A, Keler, T, Steinman, R, Schlesinger, S
Publicado 2012

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

por Williams, WB, Jones, K, Krambrink, A, Grove, D, Liu, P, Yates, NL, Moody, MA, Ferrari, G, Pollara, J, Moodie, Z, Morgan, CA, Liao, H, Montefiori, DC, Ochsenbauer, C, Kappes, J, Hammer, S, Mascola, J, Koup, R, Corey, L, Nabel, G, Gilbert, P, Churchyard, G, Keefer, M, Graham, BS, Haynes, BF, Tomaras, GD
Publicado 2012